These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 2176277)

  • 1. Marijuana effects and urinalysis after passive inhalation and oral ingestion.
    Cone EJ
    NIDA Res Monogr; 1990; 99():88-96. PubMed ID: 2176277
    [No Abstract]   [Full Text] [Related]  

  • 2. Urinary elimination half-life of delta-1-tetrahydrocannabinol-7-oic acid in heavy marijuana users after smoking.
    Johansson EK; Hollister LE; Halldin MM
    NIDA Res Monogr; 1989; 95():457-8. PubMed ID: 2561839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of smoked marijuana and oral Delta(9)-tetrahydrocannabinol in humans.
    Hart CL; Ward AS; Haney M; Comer SD; Foltin RW; Fischman MW
    Psychopharmacology (Berl); 2002 Dec; 164(4):407-15. PubMed ID: 12457271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users.
    Curran HV; Brignell C; Fletcher S; Middleton P; Henry J
    Psychopharmacology (Berl); 2002 Oct; 164(1):61-70. PubMed ID: 12373420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study investigating the acute dose-response effects of 13 mg and 17 mg Delta 9- tetrahydrocannabinol on cognitive-motor skills, subjective and autonomic measures in regular users of marijuana.
    Weinstein A; Brickner O; Lerman H; Greemland M; Bloch M; Lester H; Chisin R; Sarne Y; Mechoulam R; Bar-Hamburger R; Freedman N; Even-Sapir E
    J Psychopharmacol; 2008 Jun; 22(4):441-51. PubMed ID: 18635724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cannabis and urine samples].
    Westin AA
    Tidsskr Nor Laegeforen; 2011 Mar; 131(6):577-80. PubMed ID: 21423309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agreement between maternal cannabis use during pregnancy according to self-report and urinalysis in a population-based cohort: the Generation R Study.
    El Marroun H; Tiemeier H; Jaddoe VW; Hofman A; Verhulst FC; van den Brink W; Huizink AC
    Eur Addict Res; 2011; 17(1):37-43. PubMed ID: 20975275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between naltrexone and oral THC in heavy marijuana smokers.
    Haney M; Bisaga A; Foltin RW
    Psychopharmacology (Berl); 2003 Feb; 166(1):77-85. PubMed ID: 12491025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiles of delta 9-tetrahydrocannabinol metabolites in urine of marijuana users: preliminary observations by high performance liquid chromatography-radioimmunoassay.
    Alburges ME; Peat MA
    J Forensic Sci; 1986 Apr; 31(2):695-706. PubMed ID: 3011957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of the use of cannabis in a young population].
    Plans P; Vaqué J; Artanza MA
    Med Clin (Barc); 1986 Apr; 86(16):697-8. PubMed ID: 3016420
    [No Abstract]   [Full Text] [Related]  

  • 11. [Racing heart and angina pectoris in a 19-year-old male. Possibly the result of cannabis smoking?].
    Flesch M; Erdmann E
    MMW Fortschr Med; 2004 Apr; 146(16):16. PubMed ID: 15222494
    [No Abstract]   [Full Text] [Related]  

  • 12. Federal guidelines for marijuana screening should have lower cutoff levels. A comparison of results from immunoassays and gas chromatography-mass spectrometry.
    Smith DE; Gutgesell ME; Schwartz RH; Thorne MM; Bogema S
    Arch Pathol Lab Med; 1989 Nov; 113(11):1299-300. PubMed ID: 2554846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychological absorption. Affect investment in marijuana intoxication.
    Fabian WD; Fishkin SM
    J Nerv Ment Dis; 1991 Jan; 179(1):39-43. PubMed ID: 1985147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study assessing maternal marijuana use by urine assay during pregnancy.
    Zuckerman BS; Hingson RW; Morelock S; Amaro H; Frank D; Sorenson JR; Kayne HL; Timperi R
    NIDA Res Monogr; 1985; 57():84-93. PubMed ID: 2993891
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of thin-layer chromatography for detection of 11-nor-9-carboxy-delta9-tetrahydrocannabinol in the urine].
    Nikonova EV; Karaeva LD
    Sud Med Ekspert; 2005; 48(5):33-5. PubMed ID: 16279498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms.
    Budney AJ; Vandrey RG; Hughes JR; Moore BA; Bahrenburg B
    Drug Alcohol Depend; 2007 Jan; 86(1):22-9. PubMed ID: 16769180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response perseveration and adaptation in heavy marijuana-smoking adolescents.
    Lane SD; Cherek DR; Tcheremissine OV; Steinberg JL; Sharon JL
    Addict Behav; 2007 May; 32(5):977-90. PubMed ID: 16930850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marijuana use and increased risk of squamous cell carcinoma of the head and neck.
    Zhang ZF; Morgenstern H; Spitz MR; Tashkin DP; Yu GP; Marshall JR; Hsu TC; Schantz SP
    Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1071-8. PubMed ID: 10613339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Outline of the types of cannabis use in adolescence].
    Hachet P
    Soins Pediatr Pueric; 2003 Oct; (214):22-5. PubMed ID: 14625984
    [No Abstract]   [Full Text] [Related]  

  • 20. Comments on Hall et al.'s Australian National Drug Strategy Monograph no. 25 "The health and psychological consequences of cannabis use".
    Addiction; 1996 Jun; 91(6):759-62. PubMed ID: 8696235
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.